Skip to main content

Table 1 Patient characteristics

From: Use of speckle-tracking echocardiography–derived strain and systolic strain rate measurements to predict rejection in transplant hearts with preserved ejection fraction

Characteristic Groupa P
Control (n = 40) Rejection (n = 25)
Age, y 53.2 (11.5) 48.4 (13.5) .15
Time since transplant, y 0.98 (0.08) 1.13 (1.3) .47
Men 30 (75) 16 (64) .34
BMI, kg/m2 25.96 (5.0) 25.96 (5.9) .99
BSA, m2 1.94 (0.26) 1.87 (0.25) .26
Hypertension 17 (44) 12 (45) .73
LDL cholesterol, mg/dL 103.0 (32.47) 104.9 (39.15) .57
Diabetes mellitus 8 (20) 3 (12) .40
SBP, mm Hg 126.3 (15.3) 126.5 (15.5) .95
DBP, mm Hg 76.3 (11.3) 79.1 (10.0) .30
Heart rate, beats/min 90.2 (11.2) 94.5 (11.4) .15
Hyperlipidemia 20 (50) 16 (64) .27
QRS duration, ms 106.6 (19.5) 103.7 (25.6) .61
Cyclosporine, n (%) 16 (40) 14 (56) .21
Tacrolimus, n (%) 7 (18) 5 (20) .84
Sirolimus, n (%) 19 (48) 9 (36) .34
Azathioprine, n (%) 8 (20) 4 (16) .69
Mycophenolate mofetil, n (%) 25 (63) 21 (84) .07
Prednisone in last 12 months, n (%) 38 (95) 21 (84) .14
ACE-I/ARB, n (%) 16 (40) 6 (24) .19
Beta-blocker, n (%) 5 (13) 2 (8) .54
Statin, n (%) 20 (50) 16 (64) .27
  1. Abbreviations: BMI body mass index, BSA body surface area, DBP diastolic blood pressure, LDL low-density lipoprotein, SBP systolic blood pressure
  2. aValues are mean (SD) or No. of patients (%)